EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCV
A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype (CIMP) status and O 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation as assessed by MGMT-STP27 are the most ...
May 29, 2013
0
1